News
2don MSNOpinion
Voices: Yes, Mounjaro is set to treble in price – but don’t abandon weight-loss jabs until you read this
COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...
Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...
Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss treatments ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
5h
ScienceAlert on MSNNew Weight Loss Drug Outperformed Existing Treatment in Clinical Trial
Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...
1h
Verywell Health on MSNWegovy Is Now the Second FDA-Approved Treatment for MASH Fibrosis
Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...
WITH the price of Mounjaro set to rise and concerns about long-term affordability and access, many may be looking to turn to ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll ...
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results